Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2000
10/11/2000EP1042463A1 Target for treating atherosclerosis, obesity and type ii diabetes
10/11/2000EP1042462A1 Genetic inhibition by double-stranded rna
10/11/2000EP1042460A1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof
10/11/2000EP1042456A1 Human nucleotide pyrophosphohydrolase-2
10/11/2000EP1042455A1 HUMAN CYCLIN-DEPENDENT KINASE $i((h)PFTAIRE)
10/11/2000EP1042452A1 MULTIPLE DRUG RESISTANCE GENE atrD OF $i(ASPERGILLUS NIDULANS)
10/11/2000EP1042436A2 Method of preparing lipoproteins, lipoaminoacids, lipid esters, and glucolipids from chlorinated olive oil and/or its constituents
10/11/2000EP1042367A1 V196 dna and polypeptides
10/11/2000EP1042365A1 Compounds and methods for modulating occludin related tissue permeability
10/11/2000EP1042364A2 Antivirally active oligopeptide isolated from royal jelly
10/11/2000EP1042363A1 Novel anti-hiv immunogens (toxoids), preparation methods and use for preventing and treating aids
10/11/2000EP1042362A2 Human regulatory proteins
10/11/2000EP1042360A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/11/2000EP1042359A1 Kappa receptor opioid peptides
10/11/2000EP1042350A1 Inducible phosphofructokinase and the warburg effect
10/11/2000EP1042349A1 Using polyamide nucleic acid oligomers to engender a biological response
10/11/2000EP1042348A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes
10/11/2000EP1042346A1 86 human secreted proteins
10/11/2000EP1042343A1 Vegi, an inhibitor of angiogenesis and tumor growth
10/11/2000EP1042342A1 53 human secreted proteins
10/11/2000EP1042339A2 Carbohydrates, useful in solid delivery systems
10/11/2000EP1042312A1 PHOTOCHROMIC INDENO-FUSED NAPHTHO 2,1-b]PYRANS
10/11/2000EP1042288A1 Tripeptidyl peptidase inhibitors
10/11/2000EP1042003A1 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
10/11/2000EP1042000A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors
10/11/2000EP1041999A1 Thrombogenic polypeptide chimeras and conjugates having activity dependent upon association with tumor vascular endothelium
10/11/2000EP1041998A1 Composition and method for dermal and transdermal administration of a cytokine
10/11/2000EP1041997A2 Use of citrulline peptides derived from filaggrin for treating autoimmune diseases
10/11/2000EP1041996A1 Keratinocyte growth factor-2 formulations
10/11/2000EP1041995A1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
10/11/2000EP1041970A1 Compositions of microspheres for wound healing
10/11/2000EP1041967A1 Microparticles and their therapeutic or diagnostic use
10/11/2000EP1041890A1 Carbohydrate oxidase and use thereof in baking
10/11/2000EP1041888A1 Anti-retroviral immunogens, preparation and use
10/11/2000EP1041882A1 Transvascular delivery of a composition to an extravascular tissue of a mammal
10/11/2000EP0937101B1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them
10/11/2000EP0831100B1 Novel peptide derivatives
10/11/2000EP0719328B1 Grb3-3 gene, variants and uses thereof
10/11/2000EP0710121B1 Method for treating multiple sclerosis
10/11/2000EP0472638B1 Method for isolating receptors having a preselected specificity
10/11/2000EP0425661B1 A new method for tapping the immunological repertoire
10/11/2000CN1269835A Chimeric interleukin-6 soluble receptor/ligand protein, analoys thereof and uses thereof
10/11/2000CN1269834A Expression of gonadotropins in i (dictyostelium)
10/11/2000CN1269833A Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
10/11/2000CN1269832A Kay-novel immune system protein
10/11/2000CN1269806A Piptides containing arginine mimetic for treatment of bone metabolic disorders, their production and drugs containing these compounds
10/11/2000CN1269728A Decreased fat absorption with anti-lipase antibody
10/11/2000CN1269727A Pharmaceutical compositions containing lyosostaphin alone or in combination with antibiotic for treatment of staphylococcal infections
10/11/2000CN1269726A Fracture healing using PTHrp analogs
10/11/2000CN1269725A Product comprising at least double stranded RNA combined with at least an antiviral agent
10/11/2000CN1269724A Absorption of minerals by intestinal cells
10/11/2000CN1269722A Method and composition for modulating responsiveness to corticosteroids
10/11/2000CN1269364A Somatotropin releasing peptide
10/11/2000CN1269242A Osteogenic growth peptide medicine composite and its preparation and application
10/11/2000CN1057306C New polypeptide compound and process for preparation thereof
10/11/2000CN1057231C Modulation of AIDS virus-related events by double-stuanded RNAs
10/11/2000CN1057221C Chinese medicine capsule for treating apolexy
10/10/2000US6130325 Human P24 vesicle proteins
10/10/2000US6130318 hIL-4 mutant proteins used as antagonists or partial agonists of human interleukin 4
10/10/2000US6130316 Nucleotide sequence coding polypeptide with extracellular binding domain; for detecting modulators of immune response; for detection of cytokines; for treatment and prevention of infection, autoimmune diseases, allergy, organ rejection
10/10/2000US6130315 Substrates in which the scissile amide bond has been replaced by an activated electrophilic ketone moiety; antiinflammatory agents; antiproliferative/anticarcinogenic/antiarthritic agents; treatment of autoimmune diseases
10/10/2000US6130254 Methods for inhibiting photoaging of skin
10/10/2000US6130204 Peptides
10/10/2000US6130203 Blood coagulation proteins with modified activities, such as enhanced coagulation activities.
10/10/2000US6130202 Antiviral methods
10/10/2000US6130200 Gel composition and methods
10/10/2000US6130091 Method for obtaining a peptide derived from the respiratory syncytial virus polypeptide and bacterium expressing it
10/10/2000US6130088 Antisense modulation of telomeric repeat binding factor 1 expression
10/10/2000US6130087 Methods for generating cytotoxic T cells in vitro
10/10/2000US6130082 Expression vector coding fusion protein capable of eliciting an immune response against infection by the heterologous microorganism
10/10/2000US6130079 RAIDD, a novel death adaptor molecule
10/10/2000US6130071 Vascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereof
10/10/2000US6130069 Nucleotide sequences coding a synthetase; for the diagnosis and treatment of bacterial infections; for the detection of agonist and antagonist of bacterial infection; bactericides
10/10/2000US6130068 Dna sequence; recombinant production; antiinflammatory agents
10/10/2000US6130067 Human EDG3sb gene
10/10/2000US6130064 Amino acid sequence encoded by polynucleotide from survival motor neuron gene; diagnosis, treatment, and prevention of nervous system, reproductive, and cell proliferative disorders; antiproliferative/anticarcinogenic agents
10/10/2000US6130062 Production of proteins in host cells
10/10/2000US6130061 Isolated polynucleotide which encodes a defined amino acid sequence; stimulating thymocyte maturation/differentiation, neuroprotectants, immunosuppressants, treating alzheimer's disease; antiinflammatory agents
10/10/2000US6130060 Gene encoding for adseverin
10/10/2000US6130058 Nucleotide sequences coding for n-methylaspartic acid receptor; for drug design and drug screening; antidepressants; anticonvulsants; antiepileptic agents; antiischemic agents; treatment of stroke, cerebral palsy
10/10/2000US6130053 Method for selecting compounds for inhibition of neoplastic lesions
10/10/2000US6130052 Leukemia associated genes
10/10/2000US6130051 Human insoitol monophosphatase H1
10/10/2000US6130050 Immunoassay using antibody to specifically bind the polypeptide, then detecting or measuring complex formed; diagnosis of liver proliferative disorders
10/10/2000US6130043 Contacting sample with one prostate-specific polynucleotide or complement and detecting presence of target polynucleotide
10/10/2000US6129926 Flash flow processing of thermoplastic polymers and products made therefrom
10/10/2000US6129925 Container filled with infusion liquids and infusion preparation
10/10/2000US6129916 Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates
10/10/2000US6129915 Epidermal growth factor receptor antibodies
10/10/2000US6129914 Bispecific antibody effective to treat B-cell lymphoma and cell line
10/10/2000US6129913 Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
10/10/2000CA2196797C In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene
10/10/2000CA2196790C 17q-linked breast and ovarian cancer susceptibility gene
10/10/2000CA2106762C Bradykinin antagonist peptides
10/10/2000CA2096417C Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy
10/10/2000CA2062969C Recombinantly produced human membrane cofactor protein (mcp)
10/10/2000CA2020346C Antibiotic ge 2270 factors a1, a2, a3 and h
10/09/2000CA2303722A1 Campylobacter vaccine
10/08/2000CA2303992A1 Melanoma therapy
10/08/2000CA2303765A1 Cml therapy
1 ... 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 ... 3163